Service Specification and Optimal Pathway
The UK Mesothelioma Alliance in collaboration with the NHS England Lung Cancer Clinical Excellence Group (CEG) set up a Service Specification and Optimal Pathway for Mesothelioma Development Group.
This group included clinicians, specialists, nurses, advocates and representatives from the CEG. During 2019 they worked on drafting these complex and detailed documents.
In the Autumn of 2019 the UKMA became aware that NHS England were also working on this area by producing Quality Metrics for mesothelioma.
Originally these were to be introduced from April 2020 for implementation and adoption by NHS Specialist Commissioners.
The situation with COVID-19 has meant that the introduction date has been delayed as NHS services are focussed on COVID-19.
Professor Mick Peake, UKMA representative will maintain contact with NHS England and update accordingly.
Once they have been introduced the UKMA plans to publicise the Quality Metrics to encourage adoption and implementation and monitor this uptake across NHS Trusts.